Receive Our Newsletter

Bioverativ Enters Joint Project With UK-Based Bicycle Therapeutics



Bioverativ and a UK-based biotech company called Bicycle Therapeutics will work together to try to identify new therapies for hemophilia and also sickle cell disease.  The research will focus on using a new approach – called Bicycles – which the companies hope will lead to a new way to treat the blood disorders.

Read the full press release here: Bicycle, Bioverativ Press Release.

Comments (No comments)

Assisting and Advocating for the Bleeding Disorders Community